Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease

被引:0
作者
Kassia S. Beetham
Erin J. Howden
Nicole M. Isbel
Jeff S. Coombes
机构
[1] The University of Queensland,School of Human Movement and Nutrition Sciences
[2] School of Medicine,School of Exercise Science
[3] The University of Queensland,Department of Nephrology
[4] Australian Catholic University,undefined
[5] Baker Heart and Diabetes Institute,undefined
[6] Princess Alexandra Hospital,undefined
来源
BMC Nephrology | / 19卷
关键词
Chronic kidney disease; Renal; Kidney function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 41 条
  • [31] Comparison of glomerular filtration rates calculated by different serum cystatin C-based equations in patients with chronic kidney disease
    Lee, Hee Sun
    Rhee, Harin
    Seong, Eun Young
    Lee, Dong Won
    Lee, Soo Bong
    Kwak, Ihm Soo
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2014, 33 (01) : 45 - 51
  • [32] Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease
    Trimarchi, Hernan
    Muryan, Alexis
    Martino, Diana
    Toscano, Agostina
    Iriarte, Romina
    Campolo-Girard, Vicente
    Forrester, Mariano
    Pomeranz, Vanesa
    Fitzsimons, Clara
    Lombi, Fernando
    Young, Pablo
    Rana, Maria S.
    Alonso, Mirta
    JOURNAL OF NEPHROLOGY, 2012, 25 (06) : 1003 - 1015
  • [33] Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease
    Masaru Samura
    Keisuke Takada
    Risako Yamamoto
    Hayato Ito
    Fumio Nagumo
    Masaki Uchida
    Takenori Kurata
    Sakura Koshioka
    Yuki Enoki
    Kazuaki Taguchi
    Ryuji Higashita
    Norifumi Kunika
    Koji Tanikawa
    Kazuaki Matsumoto
    Pharmaceutical Research, 2021, 38 : 1041 - 1055
  • [34] Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease
    Samura, Masaru
    Takada, Keisuke
    Yamamoto, Risako
    Ito, Hayato
    Nagumo, Fumio
    Uchida, Masaki
    Kurata, Takenori
    Koshioka, Sakura
    Enoki, Yuki
    Taguchi, Kazuaki
    Higashita, Ryuji
    Kunika, Norifumi
    Tanikawa, Koji
    Matsumoto, Kazuaki
    PHARMACEUTICAL RESEARCH, 2021, 38 (06) : 1041 - 1055
  • [35] CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations
    Chi, Xiao-Hua
    Li, Gui-Ping
    Wang, Quan-Shi
    Qi, Yong-Shuai
    Huang, Kai
    Zhang, Qian
    Xue, Yao-Ming
    BMC NEPHROLOGY, 2017, 18
  • [36] CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations
    Xiao-Hua Chi
    Gui-Ping Li
    Quan-Shi Wang
    Yong-Shuai Qi
    Kai Huang
    Qian Zhang
    Yao-ming Xue
    BMC Nephrology, 18
  • [37] Comparison of cystatin C-based estimated glomerular filtration rate with measured glomerular filtration rate in a pediatric cohort of patients with chronic kidney disease
    Lindvig, Tilde Ostendorf
    Simonsen, Jane Angel
    Gerke, Oke
    Thiesson, Helle Charlotte
    PEDIATRIC TRANSPLANTATION, 2024, 28 (04)
  • [38] Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C are early Biomarkers of Contrast-Induced Nephropathy After Coronary Angiography in Patients With Chronic Kidney Disease
    Alharazy, Sabah Mohamed
    Kong, Norella
    Saidin, Rashidi
    Gafor, Abdul Halim Abdul
    Maskon, Oteh
    Mohd, Marlyn
    Zakaria, Syed Zulkifli Syed
    ANGIOLOGY, 2014, 65 (05) : 436 - 442
  • [39] P2y12 inhibitor monotherapy after 1-3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials
    Yu, Yanqiao
    Pan, Deng
    Bai, Ruina
    Luo, Jinwen
    Tan, Yu
    Duan, Wenhui
    Shi, Dazhuo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [40] Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study
    Mathew, Roy O.
    Sidhu, Mandeep S.
    Rihal, Charanjit S.
    Lennon, Ryan
    El-Hajjar, Mohammed
    Yager, Neil
    Lyubarova, Radmila
    Abdul-Nour, Khaled
    Weitz, Steven
    O'Cochlain, D. Fearghas
    Murthy, Vishakantha
    Levisay, Justin
    Marzo, Kevin
    Graham, John
    Dzavik, Vlad
    So, Derek
    Goodman, Shaun
    Rosenberg, Yves D.
    Pereira, Naveen
    Farkouh, Michael E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (03) : 447 - 457